This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Nestec S.a.. Active years: 2007-2010.
Company Filing History:
Years Active: 2007-2010
Title: Mark Alan Schell: Innovator in Bifidobacteria Research
Introduction
Mark Alan Schell is a notable inventor based in Athens, GA (US). He has made significant contributions to the field of microbiology, particularly in the study of bifidobacteria. With a total of 2 patents, his work has implications for both food and pharmaceutical industries.
Latest Patents
Schell's latest patents include "Serpin in bifidobacteria - A novel gene of Bifidobacteria and the polypeptides encoded thereby." This patent focuses on a gene belonging to the Serpin superfamily and its applications in producing bacterial Serpins. It also details vectors, host cells, and methods for generating bacterial Serpin polynucleotides and/or polypeptides. Another significant patent is "NCC2705—the genome of a bifidobacterium," which describes a novel microorganism of the genus and its genomic and plasmid sequence. This patent outlines methods for producing polypeptides and detecting nucleic acids or polypeptides, along with a data carrier that includes nucleotide and polypeptide sequences of NCC2705. Additionally, it discusses the strain NCC2705 and its potential use in food and pharmaceutical compositions for preventing and treating diarrhea caused by rotaviruses and pathogenic bacteria.
Career Highlights
Throughout his career, Mark Alan Schell has worked with prominent companies such as Nestec S.A. and Société des Produits Nestlé S.A. His experience in these organizations has contributed to his expertise in the field of microbiology and innovation.
Collaborations
Schell has collaborated with notable individuals in his field, including Fabrizio Arigoni and Michèle Delley. These partnerships have likely enhanced his research and development efforts.
Conclusion
Mark Alan Schell's contributions to the field of bifidobacteria research are noteworthy, with his patents paving the way for advancements in health and nutrition. His work continues to impact the scientific community and the industries that rely on microbiological innovations.